These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32951052)

  • 21. Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults.
    Paul S; Wong M; Akhabue E; Mehta RC; Kramer H; Isakova T; Carnethon MR; Wolf M; Gutiérrez OM
    J Am Heart Assoc; 2021 Aug; 10(16):e020196. PubMed ID: 34387090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults.
    Hanks LJ; Casazza K; Judd SE; Jenny NS; Gutiérrez OM
    PLoS One; 2015; 10(3):e0122885. PubMed ID: 25811862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.
    Seiler S; Rogacev KS; Roth HJ; Shafein P; Emrich I; Neuhaus S; Floege J; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1049-58. PubMed ID: 24677555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ishigami J; Taliercio JT; Feldman HI; Srivastava A; Townsend RR; Cohen DL; Horwitz EJ; Rao P; Charleston J; Fink JC; Ricardo AC; Sondheimer J; Chen TK; Wolf M; Isakova T; Appel LJ; Matsushita K;
    J Am Soc Nephrol; 2020 Aug; 31(8):1836-1846. PubMed ID: 32576601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.
    Czaya B; Faul C
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease.
    Mehta RC; Cho ME; Cai X; Lee J; Chen J; He J; Flack J; Shafi T; Saraf SL; David V; Feldman HI; Isakova T; Wolf M;
    Kidney Int; 2021 Dec; 100(6):1292-1302. PubMed ID: 34339746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGF23, Frailty, and Falls in SPRINT.
    Jovanovich A; Ginsberg C; You Z; Katz R; Ambrosius WT; Berlowitz D; Cheung AK; Cho M; Lee AK; Punzi H; Rehman S; Roumie C; Supiano MA; Wright CB; Shlipak M; Ix JH; Chonchol M
    J Am Geriatr Soc; 2021 Feb; 69(2):467-473. PubMed ID: 33289072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).
    Ix JH; Katz R; Kestenbaum BR; de Boer IH; Chonchol M; Mukamal KJ; Rifkin D; Siscovick DS; Sarnak MJ; Shlipak MG
    J Am Coll Cardiol; 2012 Jul; 60(3):200-7. PubMed ID: 22703926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
    Lyngbakken MN; Pervez MO; Brynildsen J; Pedersen MH; Sølvernes J; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2018 Feb; 52():41-47. PubMed ID: 29074091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease.
    Nam KH; Kim H; An SY; Lee M; Cha MU; Park JT; Yoo TH; Lee KB; Kim YH; Sung SA; Lee J; Kang SW; Choi KH; Ahn C; Han SH
    Sci Rep; 2018 May; 8(1):7294. PubMed ID: 29740119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.
    Shimada T; Urakawa I; Isakova T; Yamazaki Y; Epstein M; Wesseling-Perry K; Wolf M; Salusky IB; Jüppner H
    J Clin Endocrinol Metab; 2010 Feb; 95(2):578-85. PubMed ID: 19965919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women.
    Imel EA; Liu Z; McQueen AK; Acton D; Acton A; Padgett LR; Peacock M; Econs MJ
    Bone; 2016 May; 86():98-105. PubMed ID: 26965530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma total fibroblast growth factor 23 levels are associated with acute kidney injury and mortality in children with acute respiratory distress syndrome.
    Hanudel MR; Zinter MS; Chen L; Gala K; Lim M; Guglielmo M; Deshmukh T; Vangala S; Matthay M; Sapru A
    PLoS One; 2019; 14(9):e0222065. PubMed ID: 31487315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.
    Agoro R; Montagna A; Goetz R; Aligbe O; Singh G; Coe LM; Mohammadi M; Rivella S; Sitara D
    FASEB J; 2018 Jul; 32(7):3752-3764. PubMed ID: 29481308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammation.
    Parikh A; Natarajan S; Lipsitz SR; Katz SD
    Circ Heart Fail; 2011 Sep; 4(5):599-606. PubMed ID: 21705484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor 23 is pumping iron: C-terminal-fibroblast growth factor 23 cleaved peptide and its function in iron metabolism.
    Courbon G; David V
    Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):368-374. PubMed ID: 38661434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease.
    Bouma-de Krijger A; Bots ML; Vervloet MG; Blankestijn PJ; Ter Wee PW; van Zuilen AD; Wetzels JF
    Nephrol Dial Transplant; 2014 Jan; 29(1):88-97. PubMed ID: 24215017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between fibroblast growth factor 23, iron, erythropoietin, and inflammation in kidney disease.
    Babitt JL; Sitara D
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):304-310. PubMed ID: 31145704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals.
    Isakova T; Cai X; Lee J; Katz R; Cauley JA; Fried LF; Hoofnagle AN; Satterfield S; Harris TB; Shlipak MG; Sarnak MJ; Ix JH;
    J Bone Miner Res; 2016 Apr; 31(4):742-8. PubMed ID: 26590361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.
    Hanudel MR; Chua K; Rappaport M; Gabayan V; Valore E; Goltzman D; Ganz T; Nemeth E; Salusky IB
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1369-F1377. PubMed ID: 27733366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.